• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Novo buys Ziylo for glucose-responsive insulin platform fiercebiotech
    August 20, 2018
    Novo Nordisk has bought Ziylo to fuel its work on next-generation insulins. The takeover gives Novo control of a platform that could support development of insulins that respond to glucose.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service